|
NT5DC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.85990000032422E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.42149999996055E-06 |
| Normal-vs-Stage2 |
3.386000E-01 |
| Normal-vs-Stage3 |
8.35909996776962E-09 |
| Normal-vs-Stage4 |
4.42309999737489E-09 |
| Stage1-vs-Stage2 |
3.722100E-02 |
| Stage1-vs-Stage3 |
7.000200E-02 |
| Stage1-vs-Stage4 |
1.167970E-02 |
| Stage2-vs-Stage3 |
4.139800E-03 |
| Stage2-vs-Stage4 |
1.244660E-03 |
| Stage3-vs-Stage4 |
4.397800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.3621000407087E-09 |
| Normal-vs-AfricanAmerican |
6.715700E-03 |
| Normal-vs-Asian |
4.02629999995963E-06 |
| Caucasian-vs-AfricanAmerican |
3.080800E-01 |
| Caucasian-vs-Asian |
7.152200E-01 |
| AfricanAmerican-vs-Asian |
2.786400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.15490000007767E-07 |
| Normal-vs-Female |
1.68774999999011E-05 |
| Male-vs-Female |
1.685800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.80889999998624E-06 |
| Normal-vs-Age(41-60Yrs) |
2.21249999998729E-06 |
| Normal-vs-Age(61-80Yrs) |
6.13389999999381E-05 |
| Normal-vs-Age(81-100Yrs) |
3.441800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.550200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.688600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.720800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.737400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.496200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.849200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.608000E-02 |
| Classical-VS-Follicular |
5.93779999999988E-05 |
| Classical-VS-Other |
2.047000E-01 |
| Classical-VS-Normal |
1.32910005223863E-09 |
| Tall-VS-Follicular |
2.13339999999285E-06 |
| Tall-VS-Other |
5.182000E-01 |
| Tall-VS-Normal |
4.74130001926198E-09 |
| Follicular-VS-Other |
3.155600E-03 |
| Follicular-VS-Normal |
4.292400E-01 |
| Other-VS-Normal |
4.951500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.18039999999586E-05 |
| Normal-vs-N1 |
9.00899999045635E-09 |
| N0-vs-N1 |
5.862700E-03 |
|
|
